A2i Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
A2i Therapeutics - overview
Location
-, -, Israel
Primary Industry
Biotechnology
About
A2i Therapeutics was formed as a joint venture between Atomwise and FutuRx. The company operates as a developer of novel small molecule immuno-oncology agents.
Current Investors
OrbiMed Advisors, Johnson & Johnson Innovation, Takeda Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.a2i-tx.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.